abnormal gait_Tpp1<tm1Plob>/Tpp1<tm1Plob>

http://metadb.riken.jp/0001406I129S1SvC57BL6Tpp1tm1PlobTpp1tm1PlobTpp1tm1Plob

abnormal gait_Tpp1<tm1Plob>/Tpp1<tm1Plob>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• tripeptidyl peptidase I
  http://metadb.riken.jp/db/mgi_rdf/MGI:1336194

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tpp1<tm1Plob>/Tpp1<tm1Plob>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tpp1<tm1Plob>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal gait
  http://purl.obolibrary.org/obo/MP_0001406

文献

http://purl.org/net/cito/citesAsAuthority

• David E. Sleat, et.al., A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration., The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, 24
  http://rdf.ncbi.nlm.nih.gov/pubmed/15483130